Clinical Trial: OMS-I141

Trial Status: Open
Disease Type: Breast
Trial ID OMS-I141
Sponsor ID OncoSec Medical

A PHASE 2, MULTI-COHORT, OPEN-LABEL STUDY OF INTRATUMORAL TAVOKINOGENE TELSEPLASMID PLUS ELECTROPORATION IN COMBINATION WITH INTRAVENOUS EMBROLIZUMAB THERAPY WITH OR WITHOUT CHEMOTHERAPY IN PATIENTS WITH INOPERABLE LOCALLY ADVANCED OR METASTATIC TRIPLE NEGATIVE BREAST CANCER

1 Location

Locations

Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID LAE205INT3101
Sponsor ID Laekna

A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients with Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies

Principal Investigator
Shruti Tiwari, MD
3 Locations
Trial ID 20363
Sponsor ID SERENA-4

SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrozole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

Principal Investigator
Anne Favret, MD
3 Locations